Participants 78 311 7
A multicenter, double-blind, between-patient trial comparing two doses of ketazolam (15 and 30 mg) with placebo, each given once daily, in the evening, to 92 outpatients affected by generalized anxiety disorders for at least 1 month,
Participants 854 926 3
Seventy-eight patients completed the first period and 75 the whole study
